1. Mason P. Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annu Rev Neurosci 2001; 24: 737-777. PMID:
11520917.
2. Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66: 355-474. PMID:
12034378.
3. Suzuki R, Rygh LJ, Dickenson AH. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 2004; 25: 613-617. PMID:
15530638.
4. Yang J, Bae HB, Ki HG, Oh JM, Kim WM, Lee HG, et al. Different role of spinal 5-HT(hydroxytryptamine)7 receptors and descending serotonergic modulation in inflammatory pain induced in formalin and carrageenan rat models. Br J Anaesth 2014; 113: 138-147. PMID:
24129596.
5. Amaya-Castellanos E, Pineda-Farias JB, Castañeda-Corral G, Vidal-Cantú GC, Murbartián J, Rocha-González HI, et al. Blockade of 5-HT7 receptors reduces tactile allodynia in the rat. Pharmacol Biochem Behav 2011; 99: 591-597. PMID:
21693130.
6. Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sánchez-Arroyos R, et al. Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity. Pain 2010; 149: 483-494. PMID:
20399562.
7. Seyrek M, Kahraman S, Deveci MS, Yesilyurt O, Dogrul A. Systemic cannabinoids produce CB(1)-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors. Eur J Pharmacol 2010; 649: 183-194. PMID:
20868676.
8. Dogrul A, Seyrek M. Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord. Br J Pharmacol 2006; 149: 498-505. PMID:
16921395.
9. Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, et al. Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways. Anesthesiology 2010; 112: 696-710. PMID:
20179508.
10. Bardin L, Bardin M, Lavarenne J, Eschalier A. Effect of intrathecal serotonin on nociception in rats: influence of the pain test used. Exp Brain Res 1997; 113: 81-87. PMID:
9028777.
11. Sommer C. Is serotonin hyperalgesic or analgesic? Curr Pain Headache Rep 2006; 10: 101-106. PMID:
16539862.
12. Rahman W, Suzuki R, Rygh LJ, Dickenson AH. Descending serotonergic facilitation mediated through rat spinal 5HT3 receptors is unaltered following carrageenan inflammation. Neurosci Lett 2004; 361: 229-231. PMID:
15135935.
13. Wei F, Dubner R, Zou S, Ren K, Bai G, Wei D, et al. Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci 2010; 30: 8624-8636. PMID:
20573908.
14. Svensson CI, Tran TK, Fitzsimmons B, Yaksh TL, Hua XY. Descending serotonergic facilitation of spinal ERK activation and pain behavior. FEBS Lett 2006; 580: 6629-6634. PMID:
17113581.
15. Oatway MA, Chen Y, Weaver LC. The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain 2004; 110: 259-268. PMID:
15275776.
16. Galan A, Lopez-Garcia JA, Cervero F, Laird JM. Activation of spinal extracellular signaling-regulated kinase-1 and -2 by intraplantar carrageenan in rodents. Neurosci Lett 2002; 322: 37-40. PMID:
11958838.
17. Jeong SH, Heo BH, Park SH, Kim WM, Lee HG, Yoon MH, et al. Spinal noradrenergic modulation and the role of the alpha-2 receptor in the antinociceptive effect of intrathecal nefopam in the formalin test. Korean J Pain 2014; 27: 23-29. PMID:
24478897.
18. Viguier F, Michot B, Kayser V, Bernard JF, Vela JM, Hamon M, et al. GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain. Neuropharmacology 2012; 63: 1093-1106. PMID:
22820553.
19. Doly S, Fischer J, Brisorgueil MJ, Verge D, Conrath M. Pre- and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: immunocytochemical evidence. J Comp Neurol 2005; 490: 256-269. PMID:
16082681.
20. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001; 22: 153-183. PMID:
11294822.
21. Ji RR, Gereau RW 4th, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009; 60: 135-148. PMID:
19150373.
22. Galan A, Cervero F, Laird JM. Extracellular signaling-regulated kinase-1 and -2 (ERK 1/2) mediate referred hyperalgesia in a murine model of visceral pain. Brain Res Mol Brain Res 2003; 116: 126-134. PMID:
12941468.
23. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005; 114: 149-159. PMID:
15733640.
24. Adwanikar H, Karim F, Gereau RW 4th. Inflammation persistently enhances nocifensive behaviors mediated by spinal group I mGluRs through sustained ERK activation. Pain 2004; 111: 125-135. PMID:
15327816.
25. Song XS, Cao JL, Xu YB, He JH, Zhang LC, Zeng YM. Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats. Acta Pharmacol Sin 2005; 26: 789-798. PMID:
15960884.
26. Ji RR, Baba H, Brenner GJ, Woolf CJ. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 1999; 2: 1114-1119. PMID:
10570489.
27. Karim F, Wang CC, Gereau RW 4th. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 2001; 21: 3771-3779. PMID:
11356865.
28. Geranton SM, Tochiki KK, Chiu WW, Stuart SA, Hunt SP. Injury induced activation of extracellular signal-regulated kinase (ERK) in the rat rostral ventromedial medulla (RVM) is age dependant and requires the lamina I projection pathway. Mol Pain 2010; 6: 54PMID:
20840753.
29. Imbe H, Kimura A, Okamoto K, Donishi T, Aikawa F, Senba E, et al. Activation of ERK in the rostral ventromedial medulla is involved in hyperalgesia during peripheral inflammation. Brain Res 2008; 1187: 103-110. PMID:
18037394.